FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

PhRMA Wants Changes to Platform Tech Designation

PhRMA makes nine recommendations for changes to an FDA draft guidance on the platform technology designation program.

latest-news-card-1
Human Drugs

Correct Misleading AbbVie Study Description: Ali

Ali Pharmaceutical asks FDA to require AbbVie to stop saying it is using Alis Armour Thyroid in a clinical trial since it is using a biologic with a d...

latest-news-card-1
Medical Devices

Many Ideas to Approve FDA Regulation of AI: Article

Politico explores the many ideas people have for improving FDFA regulation of artificial intelligence.

latest-news-card-1
Human Drugs

Otsuka Pharmaceutical FDA-483 Released

FDA releases the form FDA-483 with five observations from an inspection at the Otsuka Pharmaceutical second factory in Tokushima, Japan.

latest-news-card-1
Medical Devices

FDA Clears Embecta Disposable Insulin Patch Pump

FDA clears an Embecta 510(k) for its Disposable Patch Pump for Insulin Delivery, intended for use by adults who require insulin to manage diabetes.

latest-news-card-1
Federal Register

Class 2 for Neuromuscular Tongue Muscle Stimulators

Federal Register notice: FDA classifies neuromuscular tongue muscle stimulators and their use for reducing snoring and obstructive sleep apnea into Cl...

latest-news-card-1
Human Drugs

Feedback Sought on Model-Informed Drug Development

CDER and CBER seek input to help advance the agencys model-informed drug development program.

Biologics

FDA Authorizes Updated Novavax Covid Vaccine

FDA grants an emergency use authorization for an updated version of Novavaxs Covid-19 vaccine that more closely targets currently circulating variants...

latest-news-card-1
Biologics

Emergent Bio Wins Mpox Vaccine Approval

FDA approves an Emergent BioSolutions supplemental BLA for an expanded indication ACAM2000, (smallpox and mpox vaccine, live) to include preventing mp...

latest-news-card-1
Human Drugs

FDA Backs CellProthera Cell Therapy Phase 3 Study

CellProthera says a recent FDA meeting led to their alignment on a planned pivotal Phase 3 trial design for its ProtheraCytes cell therapy for use in ...